Literatura académica sobre el tema "Cancer – Microbiology"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Cancer – Microbiology".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Cancer – Microbiology"
Seppa, Nathan. "Microbiology: Receptor may be cancer accomplice". Science News 173, n.º 5 (30 de septiembre de 2009): 77–78. http://dx.doi.org/10.1002/scin.2008.5591730515.
Texto completoSobti, A., R. Hamaudi y C. Hopper. "Spectra of oral cancer microbiology: a review". International Journal of Oral and Maxillofacial Surgery 44 (octubre de 2015): e146. http://dx.doi.org/10.1016/j.ijom.2015.08.812.
Texto completoGonzalez, Carmen E., Tami N. Johnson, Lisa M. Kidin, Scott Evans, Yvette DeJesus, Kenneth V. I. Rolston y Ronald Stewart Walters. "Compliance with established pneumonia core measures at MD Anderson Cancer Center in the emergency center." Journal of Clinical Oncology 30, n.º 34_suppl (1 de diciembre de 2012): 189. http://dx.doi.org/10.1200/jco.2012.30.34_suppl.189.
Texto completoG. Robayo, D. Adriana, Raquel F. Hernandez, Alveiro T. Erira, Ljubov Kandaurova, Celia L. Juarez, Victoria Juarez y Angel Cid-Arregui. "Oral Microbiota Associated with Oral and Gastroenteric Cancer". Open Microbiology Journal 14, n.º 1 (10 de febrero de 2020): 1–17. http://dx.doi.org/10.2174/1874285802014010001.
Texto completoBelusic-Gobic, Margita, Arijan Zubovic, Anamarija Predrijevac, David Harmicar, Robert Cerovic, Silvana Udovic Gobic y Lorena Zubovic. "Microbiology of wound infection after oral cancer surgery". Journal of Cranio-Maxillofacial Surgery 48, n.º 7 (julio de 2020): 700–705. http://dx.doi.org/10.1016/j.jcms.2020.05.011.
Texto completoS. Abbas, Oday, Dalia A. Abdul-Shaheed y Rand M. Anwer. "Induce Cancer by Ochratoxin A". Journal of Pure and Applied Microbiology 12, n.º 4 (30 de diciembre de 2018): 1825–28. http://dx.doi.org/10.22207/jpam.12.4.16.
Texto completoHsu-Kim, Cynthia, Jeffrey B. Hoag, Guang-Shin Cheng y Mark E. Lund. "The Microbiology of Postobstructive Pneumonia in Lung Cancer Patients". Journal of Bronchology & Interventional Pulmonology 20, n.º 3 (julio de 2013): 266–70. http://dx.doi.org/10.1097/lbr.0b013e31829ddf01.
Texto completoPeterson, D. E., G. E. Minah, C. D. Overholser, J. B. Suzuki, L. G. DePaola, D. M. Stansbury, L. T. Williams y S. C. Schimpff. "Microbiology of acute periodontal infection in myelosuppressed cancer patients." Journal of Clinical Oncology 5, n.º 9 (septiembre de 1987): 1461–68. http://dx.doi.org/10.1200/jco.1987.5.9.1461.
Texto completoFarrell, Paul. "Viruses and cancer society for general microbiology, symposium 37". FEBS Letters 194, n.º 1 (1 de enero de 1986): 192. http://dx.doi.org/10.1016/0014-5793(86)80078-3.
Texto completoBrook, Itzhak y Ronald Hirokawa. "Microbiology of Wound Infection after Head and Neck Cancer Surgery". Annals of Otology, Rhinology & Laryngology 98, n.º 5 (mayo de 1989): 323–25. http://dx.doi.org/10.1177/000348948909800501.
Texto completoTesis sobre el tema "Cancer – Microbiology"
Arat, Seda. "A Systems Biology Approach to Microbiology and Cancer". Diss., Virginia Tech, 2015. http://hdl.handle.net/10919/75149.
Texto completoPh. D.
Al, Kamal Nasrah Ali. "Immunotherapy for human breast cancer". Wright State University / OhioLINK, 2015. http://rave.ohiolink.edu/etdc/view?acc_num=wright1452814566.
Texto completoCiesielski, Francisco Isaak Nícolas [UNESP]. "Microrganismos oportunistas e exógenos na microbiota bucal de pacientes oncológicos submetidos à radioterapia de cabeça e pescoço". Universidade Estadual Paulista (UNESP), 2010. http://hdl.handle.net/11449/91426.
Texto completoFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
O objetivo deste estudo foi avaliar a ocorrência de microrganismos exógenos e oportunistas (bactérias entéricas, pseudomonados, leveduras e Helicobacter pylori) na cavidade bucal de pacientes submetidos à radioterapia para tratamento de câncer de cabeça e pescoço. Cincoenta pacientes que iria receber radioterapia foram examinados antes, durante e 30 dias após radioterapia. Amostras de saliva, mucosa e biofilme foram coletadas e os microrganismos foram detectados por cultura e Reação em Cadeia da Polimerase (PCR). Candida albicans, C. tropicalis, C. krusei, C. glabrata e C. parapsilosis foram as leveduras mais prevalentes nos pacientes submetidos a radioterapia. Gêneros Citrobacter, Enterobacter, Enterococcus, Klebsiella, Proteus, e Pseudomonas forma as bactérias mais frequentemente cultivadas. As bactérias alvo foram cultivadas de 77.8% dos pacientes edêntulos e 46.9% dos pacientes dentados 30 dias após a radioterapia. Por PCR, estes microrganismos foram detectados em todos os pacientes edêntulos e 78.1% dos pacientes dentados. Bactérias não orais e espécies de Cândida foram mais prevalentes nestes pacientes. Modificações no meio ambiente oral devido a radioterapia parecem facilitar a colonização por estes microrganismos.
The aim of this study was to evaluate the occurrence of opportunistic and exogenous microrganisms (enteric bacteria, pseudomonads, yeasts and Helicobacter pylori) in the oral cavity of patients undergoing radiotherapy (RT) for treatment of head and neck cancer. Fifty patients receiving RT were examined before, during and 30 days after RT. Saliva, mucosa, and biofilm samples were collected and microorganisms were detected by culture and Polymerase Chain Reaction (PCR). Candida albicans, C. tropicalis, C. krusei, C. glabrata and C. parapsilosis were the most prevalent yeasts in patients submitted to RT. Genera Citrobacter, Enterobacter, Enterococcus, Klebsiella, Proteus, and Pseudomonas were the most frequently cultivated bacteria. Targeted bacteria were cultivated from 77.8% edentulous and 46.9% dentate patients 30 days after RT. By PCR, these microorganisms were detected from all edentulous patients and from 78.1% of dentate patients. Non-oral bacteria and Candida species were prevalent in these patients. Modifications of the oral environment due to RT seem to facilitate the colonization of these microorganisms.
Mas, de Xaxars Rivero Teresa. "Descripció i quantificació de la microbiota intestinal associada al càncer colorectal". Doctoral thesis, Universitat de Girona, 2012. http://hdl.handle.net/10803/94513.
Texto completoEl càncer colorectal és el tipus de càncer més abundant a Espanya. Fins el 90% dels casos són d'origen espontani i la seva etiologia és desconeguda malgrat existeixen diversos factors que poden afectar en el desenvolupament tumoral, com la microbiota. L'objectiu d'aquesta tesi ha estat analitzar la composició de la comunitat microbiana en mostres de mucosa intestinal quantitativa i qualitativament. Els resultats mostren una disbiosi en els malalts de càncer colorectal i una associació amb l'augment o disminució d'espècies bacterianes, així com l'augment de determinats filotips/gèneres. També s'ha analitzat les poblacions d'estreptococs i l'exposició d'un cas clínic d'un pacient amb càncer colorectal amb una infecció causada per E. faecalis. Estudis focalitzats en aspectes més específics de la relació hoste-microbiota, així com explorar nous mecanismes induïts per bacteris són necessaris per comprendre alguns aspectes de la carcinogènesis colorectal.
Ciesielski, Francisco Isaak Nícolas. "Microrganismos oportunistas e exógenos na microbiota bucal de pacientes oncológicos submetidos à radioterapia de cabeça e pescoço /". Araçatuba : [s.n.], 2010. http://hdl.handle.net/11449/91426.
Texto completoBanca: Alvimar Lima de Castro
Banca: Luis Fernando Landucci
Resumo: O objetivo deste estudo foi avaliar a ocorrência de microrganismos exógenos e oportunistas (bactérias entéricas, pseudomonados, leveduras e Helicobacter pylori) na cavidade bucal de pacientes submetidos à radioterapia para tratamento de câncer de cabeça e pescoço. Cincoenta pacientes que iria receber radioterapia foram examinados antes, durante e 30 dias após radioterapia. Amostras de saliva, mucosa e biofilme foram coletadas e os microrganismos foram detectados por cultura e Reação em Cadeia da Polimerase (PCR). Candida albicans, C. tropicalis, C. krusei, C. glabrata e C. parapsilosis foram as leveduras mais prevalentes nos pacientes submetidos a radioterapia. Gêneros Citrobacter, Enterobacter, Enterococcus, Klebsiella, Proteus, e Pseudomonas forma as bactérias mais frequentemente cultivadas. As bactérias alvo foram cultivadas de 77.8% dos pacientes edêntulos e 46.9% dos pacientes dentados 30 dias após a radioterapia. Por PCR, estes microrganismos foram detectados em todos os pacientes edêntulos e 78.1% dos pacientes dentados. Bactérias não orais e espécies de Cândida foram mais prevalentes nestes pacientes. Modificações no meio ambiente oral devido a radioterapia parecem facilitar a colonização por estes microrganismos.
Abstract: The aim of this study was to evaluate the occurrence of opportunistic and exogenous microrganisms (enteric bacteria, pseudomonads, yeasts and Helicobacter pylori) in the oral cavity of patients undergoing radiotherapy (RT) for treatment of head and neck cancer. Fifty patients receiving RT were examined before, during and 30 days after RT. Saliva, mucosa, and biofilm samples were collected and microorganisms were detected by culture and Polymerase Chain Reaction (PCR). Candida albicans, C. tropicalis, C. krusei, C. glabrata and C. parapsilosis were the most prevalent yeasts in patients submitted to RT. Genera Citrobacter, Enterobacter, Enterococcus, Klebsiella, Proteus, and Pseudomonas were the most frequently cultivated bacteria. Targeted bacteria were cultivated from 77.8% edentulous and 46.9% dentate patients 30 days after RT. By PCR, these microorganisms were detected from all edentulous patients and from 78.1% of dentate patients. Non-oral bacteria and Candida species were prevalent in these patients. Modifications of the oral environment due to RT seem to facilitate the colonization of these microorganisms.
Mestre
Leveille, Simon. "Combination strategies in the development of oncolytic cancer therapy". Thesis, McGill University, 2012. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=106483.
Texto completoCertains virus possèdent la capacité d'exploiter les défauts métaboliques des cellules cancéreuses pour leur propre réplication. Ces virus, nommés virus oncolytiques, représentent une remarquable opportunité pour le développement de thérapies contre le cancer. Malgré cette prédisposition, certaines caractéristiques des virus oncolytiques ne sont pas optimales pour cette fonction et pourraient être améliorées. Dans cette optique, des stratégies visant à augmenter l'oncolyse induite par le virus Vesicular Stomatitis (VSV) ont été développées et testées chez la souris au cours de ce doctorat. Dans un premier temps, VSV a été modifié génétiquement afin qu'il exprime l'enzyme suicide CD ::UPRT lui permettant de réaliser la conversion d'un composé non-toxique administré de façon systémique en composé cytotoxique uniquement au site de la tumeur. La stratégie a permis de démontrer une augmentation synergique de la lyse des cellules cancéreuses ainsi que l'induction de la mort de cellules cancéreuses non infectées et partiellement résistantes au VSV. De plus, la combinaison in vivo a été optimisée afin de tenir compte de la cinétique de réplication du virus à la tumeur ainsi que de la biodisponibilité de la drogue. Les résultats ont permis non seulement d'obtenir une amélioration de l'effet thérapeutique mais également de souligner d'importantes caractéristiques de la réplication virale in vivo. Dans une seconde stratégie, VSV a été combiné avec une approche d'immunomodulation ayant pour but d'engendrer une réponse immunitaire acquise spécifique à la tumeur. En employant le facteur de croissance Flt3L qui favorise la prolifération et la différentiation des cellules dendritiques, la capacité de présentation d'antigènes a été grandement renforcée simultanément à l'oncolyse induite par VSV. En dépit du fait que la combinaison n'a que partiellement amélioré l'effet thérapeutique, elle a révélé un aspect inattendu de la réponse immunitaire engendrée par VSV. Les résultats ont démontré que VSV affecte grandement la viabilité des cellules immunitaires et des cellules dendritiques à la tumeur, qu'il bloque leur migration aux organes lymphatiques et que, par conséquent, la présentation d'antigènes tumoraux est abolie. La démonstration de l'absence de présentation d'antigènes tumoraux suivant le traitement oncolytique de VSV représente un important concept expliquant la piètre capacité de VSV en ce qui a trait à l'induction d'une réponse immunitaire aquise spécifique à la tumeur. En conclusion, les stratégies développées aux cours de ces travaux ont permis d'améliorer les propriétés oncolytiques de VSV ainsi que de grandement contribuer à la compréhension de la thérapie anti-cancer de VSV.
Lampraki, Eirini-Maria. "Role of the histone demethylase KDM6A in pancreatic cancer". Thesis, University of Glasgow, 2018. http://theses.gla.ac.uk/38933/.
Texto completoPlummer, Kathleen Hope. "Cancer and Infection". Scholar Commons, 2014. https://scholarcommons.usf.edu/etd/5293.
Texto completoHand, Nicholas. "Development of a Recombinant Attenuated Salmonella Cancer Vaccine". Thesis, The George Washington University, 2017. http://pqdtopen.proquest.com/#viewpdf?dispub=10635177.
Texto completoNew treatments for neuroblastoma are desperately needed; high-risk neuroblastoma patients have a less than 50% five-year survival rate despite intensive treatment. The greatest impact on improving survival rates for cancer patients in recent years is the result of a number of immunotherapeutic approaches. A proportion of high-risk neuroblastoma patients undergo spontaneous regression, possibly mediated by the immune system, indicating the potential of immunotherapies targeting neuroblastoma-associated antigens. Recombinant attenuated Salmonella vaccines (RASV) are cost-effective and have shown efficacy against a number of pathogen-associated antigens and are easily adapted for use as cancer immunotherapies. Here we cloned survivin, a neuroblastoma tumor-associated antigen into RASV expression plasmids to develop 24 RASV candidate vaccines with an array of select phenotypes. While conventional recombinant attenuated Salmonella vaccines are permanently attenuated, the RASV used here are engineered with inducible in vivo attenuation and other delayed phenotypes shown to improve immune responses. Survivin expression did not impact the growth or stability of any of the RASV constructs. Six of the constructs were tested in vivo, the RASV survived in the gut lumen, and all RASV-immunized mice produced anti-Salmonella responses. Protein/adjuvant immunized mice produced humoral and cellular survivin specific immune responses; however two independent in vivo experiments showed that no survivin specific immune responses were induced in survivin-expressing RASV immunized mice. Based on the results, a number of improvements to the future development of the vaccine are suggested.
Riggio, Alessandra I. "The role of Runx1 in genetic models of breast cancer". Thesis, University of Glasgow, 2017. http://theses.gla.ac.uk/9103/.
Texto completoLibros sobre el tema "Cancer – Microbiology"
Khan, Abdul Arif. Bacteria and Cancer. Dordrecht: Springer Netherlands, 2012.
Buscar texto completoThe cancer microbe. Los Angeles: Aries Rising Press, 1990.
Buscar texto completoRubin, Eric. Modulation of Protein Stability in Cancer Therapy. New York, NY: Springer-Verlag New York, 2009.
Buscar texto completoMolecular biology of cancer. Oxford, UK: Bios Scientific Publishers, 1997.
Buscar texto completoMacdonald, F. Molecular biology of cancer. 2a ed. London: Taylor & Francis, 2004.
Buscar texto completoPrinciples and practice of cancer infectious diseases. New York: Humana Pres/Springer, 2011.
Buscar texto completoInternational, Duran-Reynals Symposium Viruses Oncogenes and Cancer (3rd 1984 Barcelona). Viruses, oncogenes and cancer: Third International Duran-Reynals Symposium , Viruses, Oncogenes and Cancer, Barcelona, Spain, May 14-17, 1984. Basel: Karger, 1985.
Buscar texto completoHoughton, Peter J. y Robert Arceci. Molecularly targeted therapy for childhood cancer. New York: Springer, 2010.
Buscar texto completoLidbeck, Ann. Studies on the impact of Lactobacillus acidophilus on human microflora and some cancer-related intestinal ecological variables. [S.l: s.n.], 1991.
Buscar texto completoStudies on the impact of lactobacillus acidophilus on human microflora and some cancer-related intestinal ecological variables. Stockholm: Kong. Carolinska Medico Chirurgiska Institutet, 1991.
Buscar texto completoCapítulos de libros sobre el tema "Cancer – Microbiology"
Arman, E., N. Katzir, G. Rechavi y D. Givol. "Transposable Elements and Cancer". En Current Topics in Microbiology and Immunology, 90–97. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-71562-4_12.
Texto completoLeoh, Lai Sum, Tracy R. Daniels-Wells y Manuel L. Penichet. "IgE Immunotherapy Against Cancer". En Current Topics in Microbiology and Immunology, 109–49. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13725-4_6.
Texto completoGoldberg, Monica V. y Charles G. Drake. "LAG-3 in Cancer Immunotherapy". En Current Topics in Microbiology and Immunology, 269–78. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/82_2010_114.
Texto completoDobbelstein, M. "Replicating Adenoviruses in Cancer Therapy". En Current Topics in Microbiology and Immunology, 291–334. Berlin, Heidelberg: Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-662-05599-1_9.
Texto completoPiazuelo, M. Blanca, Rachel P. Riechelmann, Keith T. Wilson y Holly M. Scott Algood. "Resolution of Gastric Cancer-Promoting Inflammation: A Novel Strategy for Anti-cancer Therapy". En Current Topics in Microbiology and Immunology, 319–59. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-15138-6_13.
Texto completoIrish, Jonathan M. y Deon B. Doxie. "High-Dimensional Single-Cell Cancer Biology". En Current Topics in Microbiology and Immunology, 1–21. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/82_2014_367.
Texto completoLawrence, Toby. "Macrophages and NF-κB in Cancer". En Current Topics in Microbiology and Immunology, 171–84. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/82_2010_100.
Texto completoAli, Omar A. y David J. Mooney. "Immunologically Active Biomaterials for Cancer Therapy". En Current Topics in Microbiology and Immunology, 279–97. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/82_2010_69.
Texto completoRundqvist, Helene y Randall S. Johnson. "Hypoxia and Metastasis in Breast Cancer". En Current Topics in Microbiology and Immunology, 121–39. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/82_2010_77.
Texto completoRoth, Anna y Sven Diederichs. "Long Noncoding RNAs in Lung Cancer". En Current Topics in Microbiology and Immunology, 57–110. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/82_2015_444.
Texto completoActas de conferencias sobre el tema "Cancer – Microbiology"
García-Mena, Jaime, Fernando Hernández-Quiroz, Selvasankar Murugesan, Cristina Velazquez-Martínez, Loan Villalobos-Flores, Otoniel Maya-Lucas, Alberto Piña-Escobedo et al. "The Vaginal and Fecal Microbiota associated to cervical cancer development in a mice model." En 1st International Electronic Conference on Microbiology. Basel, Switzerland: MDPI, 2020. http://dx.doi.org/10.3390/ecm2020-07098.
Texto completoSahara, A. L., F. Ibrahim, M. N. Massi y A. Yasmon. "Association of Chlamydia trachomatis, Mycoplasma spp., Ureaplasma urealyticum and U. parvum with Human Papillomavirus in Patients with Cervical Cancer". En 10th International Seminar and 12th Congress of Indonesian Society for Microbiology (ISISM 2019). Paris, France: Atlantis Press, 2021. http://dx.doi.org/10.2991/absr.k.210810.003.
Texto completo